Bristol Myers Squibb agreed to buy schizophrenia drug maker Karuna Therapeutics in a $14 billion deal.
Share:
More In Business
AI Pervades Everyday Life With Almost No Oversight. States Are Now Scrambling To Catch Up
Lawmakers in at least seven states are taking big legislative swings to regulate bias in artificial intelligence.
So...Bitcoin Just Hit an All-Time High
Spot Bitcoin ETF glee and pre-halving hype combined to top the cryptocurrency's previous record from November 2021.
'Spring Clean' Your Finances: Three Things You Can Do Today!
Spring has sprung! Time to tackle more than your garden.
Long Live! Eagles Center Jason Kelce Retires After 13 NFL Seasons
Time for Kylie to get that cat?
Supreme Court Restores Trump to Ballot, Overriding State Attempts For Ban
The U.S. Supreme Court unanimously decided Monday to restore former president Donald Trump to 2024 presidential primary ballots. The court Monday rejected state attempts to hold the Republican former president accountable for the Capitol riot.
These Are the Absolute Best Destinations for Spring Break Camping
With warmer days and holidays ahead, it’s time to start planning.
JetBlue and Spirit End Merger Plan — Leaving Customers Dispirited and Blue
JetBlue and Spirit Airlines are ending their proposed $3.8 billion merger after a federal judge blocked the deal, ruling it would hurt competition.
Forget Timothée and Zendaya: Dune Is All About Supply-Chain Issues
The collapse of our own global economy as explained by "Dune."
Voyager Ventures Has Confidence Sustainable Tech Is Just Better
Voyager Ventures founding partners Sarah Sclarsic and Sierra Peterson discuss how they choose products and companies to invest in, and why there’s such high demand for sustainable tech.
